. "2010 \u0569\u057E\u0561\u056F\u0561\u0576\u056B \u0570\u0578\u0582\u056C\u056B\u057D\u056B\u0576 \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E \u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E"@hy . . . . . . . . "scientific article (publication date: 24 July 2010)"@en . "im Juli 2010 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial"@en . "article publi\u00E9 dans la revue scientifique The Lancet"@fr . "Bell-McGuinn KM" . "20609468" . "245-51" . . . "Scott C" . . "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial"@ast . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u0438\u043F\u043D\u0456 2010"@uk . . . "Audeh MW" . . . . "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial"@en . . . "2010-07-24T00:00:00Z"^^ . . . . . . . "\u0D36\u0D3E\u0D38\u0D4D\u0D24\u0D4D\u0D30\u0D2A\u0D4D\u0D30\u0D2C\u0D28\u0D4D\u0D27\u0D02\u200B"@ml . . . . . . "1724576" . "Loman N" . "2010 \u0569\u0578\u0582\u0561\u056F\u0561\u0576\u056B \u0545\u0578\u0582\u056C\u056B\u057D\u056B\u0576 \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u0578\u0582\u0561\u056E \u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0575\u0585\u0564\u0578\u0582\u0561\u056E"@hyw . . . . "Penson RT" . . . . . . . . . "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial"@en . . "Oaknin A" . . . . . . . . . . "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial"@ast . . . . . . . . . "Carmichael J" . . . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 (\u0646\u0634\u0631\u062A \u0641\u064A 24-7-2010)"@ar . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2010"@ast . . . . . . . . . . . . . . . . . "376" . . . . . . . "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial"@en . "Wickens M" . "Matulonis U" . "10.1016/S0140-6736(10)60893-8" . . . "Lu K" . "Powell B" . "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial"@ast . "wetenschappelijk artikel (gepubliceerd op 2010/07/24)"@nl . . . "Friedlander M" . . "9737" . "Tutt A" .